JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
+6.87%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$167M
AUM Growth
+$167M
(+5.8%)
Cap. Flow
+$5.74M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
89.11%
Holding
67
New
16
Increased
7
Reduced
24
Closed
12
Top Buys
| 1 |
Boyd Gaming
BYD
|
$64.3M |
| 2 |
Nu Holdings
NU
|
$11.7M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
$6.99M |
| 4 |
Incyte
INCY
|
$1.18M |
| 5 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$1.02M |
Top Sells
| 1 |
Mercado Libre
MELI
|
$18.9M |
| 2 |
StoneCo
STNE
|
$16.6M |
| 3 |
Sigma Lithium
SGML
|
$11.6M |
| 4 |
XP
XP
|
$10.8M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
$4.96M |
Sector Composition
| 1 | Consumer Discretionary | 38.57% |
| 2 | Financials | 26.51% |
| 3 | Healthcare | 11.54% |
| 4 | Materials | 3.69% |
| 5 | Energy | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Becton Dickinson
BDX
$55.3B
| $336K | 0.2% |
1,379
-4
| -0.3% | -$975 |
|
27
Vinci Compass Investments Ltd. Class A Common Shares
VINP
$636M
| $332K | 0.2% |
30,300
+13,950
| +85% | +$153K |
|
28
Molina Healthcare
MOH
$9.8B
| $329K | 0.2% |
910
-3
| -0.3% | -$1.08K |
|
29
AbbVie
ABBV
$372B
| $320K | 0.19% |
2,065
-7
| -0.3% | -$1.09K |
|
30
BioMarin Pharmaceuticals
BMRN
$11.2B
| $302K | 0.18% |
3,132
+419
| +15% | +$40.4K |
|
31
Madrigal Pharmaceuticals
MDGL
$9.76B
| $302K | 0.18% |
+1,305
| New | +$302K |
|
32
Centene
CNC
$14.3B
| $295K | 0.18% |
3,981
-13
| -0.3% | -$965 |
|
33
Freeport-McMoran
FCX
$63.7B
| $293K | 0.18% |
+6,888
| New | +$293K |
|
34
Shell
SHEL
$215B
| $262K | 0.16% |
3,975
| – | – |
|
35
Rhythm Pharmaceuticals
RYTM
$6.85B
| $261K | 0.16% |
+5,688
| New | +$261K |
|
36
Jacobs Solutions
J
$17.5B
| $258K | 0.15% |
1,984
| – | – |
|
37
Cigna
CI
$80.3B
| $255K | 0.15% |
850
-3
| -0.4% | -$898 |
|
38
Pfizer
PFE
$141B
| $247K | 0.15% |
8,564
-27
| -0.3% | -$777 |
|
39
Immunocore
IMCR
$1.62B
| $230K | 0.14% |
+3,371
| New | +$230K |
|
|
KRTX
40
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $222K | 0.13% |
+701
| New | +$222K |
|
41
Penumbra
PEN
$10.6B
| $207K | 0.12% |
+824
| New | +$207K |
|
42
HCA Healthcare
HCA
$94.5B
| $205K | 0.12% |
+757
| New | +$205K |
|
|
OIBR.C
43
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
| $104K | 0.06% |
575,000
| – | – |
|
44
AbCellera Biologics
ABCL
$1.25B
| $99.5K | 0.06% |
+17,417
| New | +$99.5K |
|
45
BioCryst Pharmaceuticals
BCRX
$1.74B
| $63.8K | 0.04% |
+10,650
| New | +$63.8K |
|
46
Kodiak Sciences
KOD
$478M
| $45.8K | 0.03% |
+15,079
| New | +$45.8K |
|
47
Cerus
CERS
$251M
| $30.7K | 0.02% |
+14,231
| New | +$30.7K |
|
|
DBVT
48
DBV Technologies
DBVT
$264M
| $11.1K | 0.01% |
+11,658
| New | +$11.1K |
|
49
Ascendis Pharma
ASND
$11.8B
| – | – |
-2,305
| Closed | -$216K |
|
50
Galicia Financial Group
GGAL
$6.31B
| – | – |
-12,200
| Closed | -$159K |
|